WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

NMPA Solicits Public Comments on Drug Contract Manufacturing Document In order to strengthen the supervision and management of pharmaceutical contract manufacture and promote the high-quality development of the pharmaceutical industry, the ...
(11/5/2024)

Asian Market Rattled by Trump Tariffs: Yang Re... (11/27/2024)

Rise In Clinical Trial Activity Will Support H... (11/26/2024)

Cancer Incidence and Mortality in China, 2022 ... (11/22/2024)

69 New Drugs Granted Breakthru Therapy Designa... (11/21/2024)

Promoting Collaboration in Regional Healthcar... (11/20/2024)

Probe of AstraZeneca Executive in China Raises... (11/20/2024)

Pharma BoardRoom Interview of Renaud Gabay – ... (11/19/2024)

When BeiGene Takes Off 'Bei' and Why NewCo Now... (11/19/2024)

China on the Move: New Level of Opening up in ... (11/14/2024)

Passage to Asia: Early Access for Innovative T... (11/14/2024)

How China's Anti-Espionage Law Could Impact Ph... (11/13/2024)

Life Sciences M&A Trends for 2023 And 2024 (Th... (11/12/2024)

Recent Executive Moves (11/29/2024) AstraZeneca's Enhertu Secures Reimbursem... (11/28/2024) BeOne Secures EU Approval for First-Line... (11/28/2024) NMPA Solicits Public Comments on the Pro... (11/28/2024) NHSA and MOHRSS Announce the 2024 Nation... (11/28/2024) NHSA Issues Guidelines for Managing Pric... (11/28/2024) China Introduces New Policy to Strengthe... (11/27/2024) NHSA: Policies in Development to Synchro... (11/27/2024) Policy Change Set to Advance Cell and Ge... (11/27/2024) CMS's CMS-D005 Gets Green Light for Its ... (11/27/2024) NMPA Accepts Akeso's sNDA for Penpulimab... (11/27/2024) Hengrui Initiates Clinical Trial for SHR... (11/27/2024) Kelun's Merck-partnered TROP2 ADC sac-TM... (11/27/2024) ChP Commission Approves Chinese Pharmac... (11/27/2024) Snapshot of BMI System Financial Perform... (11/26/2024) China's Real-World Data Pilot Drives Glo... (11/25/2024) DP Tech and Lepu Biopharma Enter ADC Par... (11/25/2024) Rui Thera Present Clinical Trial Results... (11/25/2024)

SMEI: Chinese Terminal Drug Market Fell 1.9% in H1/2024... Nine Pharma MNCs Grew Their Combined China Revenue at 1... Data Review: Chinese Drug Market 2016-2023 Review of Online Drug Sales Growth in China 2021-2023 Mainland China's Pharmaceutical Sales to Reach $345B by...

BeOne Secures EU Approval for First-Line Checkpoint Blo... AstraZeneca's Enhertu Secures Reimbursement Listing Des... Kelun's Merck-partnered TROP2 ADC sac-TMT Approved for... Policy Change Set to Advance Cell and Gene Therapy in C... Kanglin Biotech Announces $20M Series A Financing to Ad...

NMPA Solicits Public Comments on the Provisions for the... ChP Commission Approves Chinese Pharmacopeia 2025 NMPA Annouces Adoption of ICH Guideline E11A for Pediat... CDE Issues the Guidelines for Application of Disease Re... CDE Issues the Technical Guidelines for Clinical Pharma...

NHSA Issues Guidelines for Managing Pricing Risks of Sh... NHSA and MOHRSS Announce the 2024 National Drug Reimbur... NHSA: Policies in Development to Synchronize Medical In... China Introduces New Policy to Strengthen Hierarchical ... Snapshot of BMI System Financial Performance in 3Qs/202...

Congress Debates Biosecure Act Amid Report Highlighting... China Targets AstraZeneca in BMI Fraud Probe over Tagri... AstraZeneca China President Under Investigation Amid Br... BeiGene Executive Under Investigation in China Amid Scr... Rouse: China's Rapid Rise in Global Innovation Strength...

FDA Issues Warning to Tianjin Darentang for Manufacturi... Shanghai Pharma Considers API Partnerships with Indian ... Aurobindo Challenges China in the Global Penicillin G M... India Mulls New PLI Scheme to Reduce Chinese API Depend... FDA Criticizes Chinese API Producer for Deceptive Pract...

Hengrui Initiates Clinical Trial for SHR-1826, a c-Met ... NMPA Accepts Akeso's sNDA for Penpulimab Plus Anlotinib... CMS's CMS-D005 Gets Green Light for Its Obesity Drug Tr... Zhongsheng Announces Promising Phase II Results for Wei... Rui Thera Present Clinical Trial Results of CD19 CAR NK...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...